Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid to reduce mortality and transfusion in bleeding trauma patients
IRCT2016040816473N6Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tranexamic acid in Bleeding, sponsored by Tabriz University of Medical Sciences. Primary endpoints: Mortality and Need for blood transfusion. Started Dec 2014; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Bleeding
Beyond the preview
Go deeper on IRCT2016040816473N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016040816473N6.